Cocrystal Pharma, Inc. (COCP) vs Marker Therapeutics, Inc. (MRKR)

A side-by-side comparison of Cocrystal Pharma, Inc. and Marker Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — COCP vs MRKR

growth of $100 · dividends reinvested · last 10y
COCP -99.4% (-39.6%/yr)MRKR -98.2% (-33.2%/yr)MRKR compounded faster over this window
050100150Start $10020182020202220242026$1$2
COCP MRKR

COCP vs MRKR: by the numbers

  • •MRKR is the larger company ($17M vs $15M market cap).
  • •Both run net losses; MRKR's is the smaller (-706.23% vs -3011.52% net margin).

Metrics side by side

Valuation

MetricCOCPMRKR
P/S ratio46.7313.89
P/B ratio14.771.41

Profitability

MetricCOCPMRKR
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin-3011.52%-706.23%
ROE-951.92%-71.57%
ROIC-497.29%-88.07%

Growth (annualized)

MetricCOCPMRKR
Revenue CAGR (5Y)91.55%N/A
Total return CAGR (5Y)-37.50%-42.13%

Frequently asked

How have COCP and MRKR total returns compared?
Over the past 10 years, COCP delivered -39.76% and MRKR delivered -33.25% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.